Search This Blog

Wednesday, November 13, 2019

Innate Pharma reports 9M results

Innate Pharma (NASDAQ:IPHA): 9M Revenue of €65.4M (+200.0% Y/Y)
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)